CASRAI Dictionary

Author: MCP Service

  • UK R&D Investment 2026: Grant Pipeline Impact for Institutions

    The UK government has committed £55.4 billion in detailed Department for Science, Innovation and Technology (DSIT) research and development allocations for the financial years 2026/27 to 2029/30, part of a wider £58.5 billion real-terms R&D budget for the period. UK Research and Innovation (UKRI) alone will deliver £38.6 billion of that total, rising to nearly £10 billion a year by 2029/30. For research administrators, the practical question is not the headline figure but what it does to grant pipelines, funder call volumes, and institutional planning cycles over the next four years.

    UK research and development investment 2026 refers to the multi-year DSIT and UKRI budget settlement, published 30 October 2025, that sets funding envelopes for UK public research bodies from 2026/27 through 2029/30. This is a spending-review allocation, not a single-year grant round — and that distinction shapes how institutions should plan.

    Contents

    What is changing in UK R&D investment for 2026?

    DSIT’s overall R&D budget will grow in real terms across the current Spending Review period, reaching £58.5 billion between 2026/27 and 2029/30, according to the department’s published R&D plans. Of that total, £55.4 billion has been allocated in detail across named organisations and programmes, with the remainder — covering programmes still being finalised — to be confirmed later.

    This is a multi-year settlement rather than a single Budget announcement. It replaces annual uncertainty with a four-year envelope, which changes how institutions can realistically plan grant-writing capacity, co-investment commitments, and infrastructure bids.

    How is the £55.4bn allocation broken down by organisation?

    UKRI is the largest single recipient, with an expected £38.6 billion across the four years — its budget rising from £8.811 billion in 2025/26 to £9.986 billion in 2029/30. A more detailed breakdown of UKRI’s own council-level budgets followed in December 2025. The remaining allocation is split across UK contributions to EU programmes (including Horizon Europe and its successor), the UK Space Agency, the Met Office, the Advanced Research and Invention Agency (ARIA), the National Academies, the Office for Life Sciences, the National Measurement System, and the AI Security Institute (AISI).

    Organisation / programme 2025/26 (£m) 2029/30 (£m) Total 2026/27–2029/30 (£m)
    UK Research and Innovation (UKRI) 8,811 9,986 38,586
    UK contribution to EU programmes 2,736 2,200 8,716
    UK Space Agency 668 720 2,798
    Met Office 310 347 1,467
    ARIA 184 400 1,220
    Office for Life Sciences 129 146 925
    National Academies 217 235 910
    National Measurement System 130 145 558
    AI Security Institute (AISI) 66 60 240

    Source: DSIT, “Research and Development (R&D) plans to 2029/2030”, published 30 October 2025. Figures are planning allocations and, per DSIT’s own disclaimer, subject to in-year reallocation under its new “agile” budget-management approach.

    What does this mean for institutional grant pipelines?

    A rising, multi-year UKRI envelope — from £9.220 billion in 2026/27 to £9.986 billion by 2029/30 — gives research offices a firmer basis for forward-loading grant pipelines than the single-year settlements common in prior spending rounds. Institutions can use the published trajectory to model realistic co-investment and matched-funding exposure three to four years out, rather than reacting to annual uncertainty.

    DSIT itself frames its new approach as more agile: funding can move across financial years where projects are delayed, be reallocated where a programme underspends, or be deprioritised where it is not delivering. That flexibility cuts both ways for pipeline planning — a confirmed four-year envelope is more predictable in total, but individual scheme budgets within it may shift year to year as DSIT and UKRI reprioritise.

    • Build grant-pipeline forecasts around the confirmed multi-year UKRI trajectory, not single-year headline figures.
    • Track the UK contribution to EU programmes carefully — it falls from £2.736 billion (2025/26) to £2.121 billion (2026/27) as Horizon Europe Guarantee costs wind down, which affects institutions relying on guarantee-funded EU collaborations.
    • Monitor ARIA’s rapid growth (from £184 million to £400 million across the period) as a distinct, high-risk/high-reward funding route worth separate pipeline tracking from mainstream UKRI council schemes.

    Will funder call volumes and success rates change?

    UKRI’s own overall research and innovation budget is confirmed as rising during this Spending Review period, reaching almost £10 billion annually by 2030. A rising overall envelope does not automatically translate into proportionally more open calls — much depends on how UKRI’s nine councils allocate the increase between responsive-mode schemes, strategic priority programmes, and infrastructure.

    DSIT has stated three explicit R&D priorities guiding allocation: protecting curiosity-driven, foundational science; supporting strategic government and societal priorities; and targeting innovative, UK-based company scale-up and growth. Research administrators should expect call volumes to grow unevenly across these three streams rather than uniformly across all disciplines.

    Answer-first questions research administrators are asking

    What is the UK government’s total R&D budget for 2026/27?

    DSIT’s overall R&D budget totals £58.5 billion across 2026/27–2029/30, with £55.4 billion of that detailed by organisation in DSIT’s published plans as of 30 October 2025. UKRI is the largest single component, at £38.6 billion over the same four years.

    How much has UKRI’s budget increased?

    UKRI’s budget rises from £8.811 billion in 2025/26 to £9.220 billion in 2026/27, reaching £9.986 billion by 2029/30 — an increase of roughly £1.18 billion, or 13%, across the Spending Review period, per DSIT’s published allocation table.

    Why is the UK’s EU programme contribution falling?

    The UK’s contribution to EU programmes, including Horizon Europe, drops from £2.736 billion in 2025/26 to £2.121 billion in 2026/27 as Horizon Europe Guarantee costs wind down and the UK’s automatic correction mechanism under its association agreement takes effect, per DSIT.

    What return does public R&D investment generate?

    DSIT’s research states that each pound of public R&D investment leverages, on average, £2 of private R&D investment and generates £8 of net benefit in the long run, citing its “Value of Public R&D” research report (DSIT 2025/036).

    What should research offices do now?

    Institutional research offices, grants teams, and pro-vice-chancellors for research should treat this settlement as a four-year planning input rather than a one-off announcement.

    1. Re-baseline internal grant-pipeline forecasts against the confirmed year-by-year UKRI figures rather than the single £55.4 billion or £38.6 billion headline totals.
    2. Flag EU-programme-dependent projects for early review given the falling Horizon Europe Guarantee allocation.
    3. Build ARIA into distinct pipeline tracking, separate from mainstream UKRI responsive-mode schemes, given its faster proportional growth.
    4. Watch for UKRI’s own council-level budget detail and DSIT’s in-year reallocation decisions, since both bodies have flagged an “agile” approach that can shift funding between years and schemes.

    Outlook: the next four years

    The confirmed trajectory to nearly £10 billion in annual UKRI funding by 2029/30, inside a wider £58.5 billion DSIT envelope, gives UK research administration a rare degree of multi-year visibility. The practical work now shifts from interpreting the headline figure to modelling how each council, scheme, and international programme within it will move — a task best served by revisiting institutional grant-pipeline forecasts against DSIT’s published tables rather than summary press coverage. Sound research administration practice in this period means tracking these allocations at the same granularity DSIT itself now publishes them.

  • UKRI Funding Buckets Explained for Grant Holders

    UKRI funding buckets are the four categories — curiosity-driven research, strategic government and societal priorities, supporting innovative companies, and a cross-cutting “enabling and strengthening UK R&D” layer — into which UK Research and Innovation now allocates its £38.6 billion 2026–2030 budget. The model replaces council-by-council settlements with outcome-led pots, and it will shape how every future grant call is designed through to the 2030 spending review deadline.

    UK Research and Innovation (UKRI) is the UK’s largest public funder of research and innovation, distributing money through seven research councils, Research England and Innovate UK. From April 2026, UKRI directs the majority of that money through the new bucket structure rather than through traditional per-council budget lines — the biggest change to its allocation model since UKRI was created in 2018.

    What are UKRI’s funding buckets?

    A UKRI funding bucket is one of the strategic investment categories UKRI now uses to allocate its budget, replacing the previous practice of setting a fixed annual budget for each research council individually. The Department for Science, Innovation and Technology (DSIT) set out the underlying “three R&D priorities” in its 30 October 2025 spending plans; UKRI applied these to its £38.6 billion allocation in its 17 December 2025 budget explainer.

    UKRI’s own framing names three “priority buckets”:

    • Curiosity-driven, foundational research — applicant-led grants and block grants such as Quality-related (QR) funding to English universities.
    • Strategic government and societal priorities — targeted programmes aligned to the government’s Modern Industrial Strategy sectors and wider missions.
    • Supporting innovative companies — commercialisation, knowledge exchange and business scale-up funding, delivered mainly through Innovate UK.

    A fourth, cross-cutting category — enabling and strengthening UK R&D — funds the infrastructure, talent and institutes underpinning all three priority buckets. UKRI does not brand it a fourth “priority,” but it has its own budget line (Table 9 of the explainer), and sector analysts describe it as functioning as a de facto fourth bucket.

    How much money sits in each bucket?

    UKRI’s 17 December 2025 explainer publishes exact four-year totals for the 2026–27 to 2029–30 spending review (SR) period, broken down by bucket:

    Bucket SR-period total What it funds
    1. Curiosity-driven research £14.5 billion Applicant-led grants (£3.3bn), QR funding to universities (£8.9bn), institutes and open-access infrastructure (£2.3bn)
    2. Strategic government and societal priorities £8.3 billion Industrial Strategy sector programmes (£4.5bn), the R&D Missions Accelerator (£500m), the Edinburgh supercomputer (£750m)
    3. Supporting innovative companies £7.4 billion Innovate UK-led commercialisation, HEIF, the Local Innovation Partnership Fund (£440m)
    4. Enabling and strengthening UK R&D £8.4 billion Institutes (£1.6bn), collective talent/doctoral funding (£3.5bn), infrastructure (£2.1bn)

    Adding all four lines gives UKRI’s full four-year settlement of £38.586 billion, rising from £9.22 billion in 2026–27 to £9.99 billion in 2029–30 — the “near-£10 billion” annual run-rate UKRI and sector commentators now reference for the end of the spending review period.

    Three buckets or four? Why the count matters

    The discrepancy between “three priority buckets” and a widely reported “fourth bucket” is not a labelling quibble — it changes how grant holders should read UKRI’s own communications. UKRI’s explainer text still says “investment in three priority buckets,” yet the same document allocates £8.4 billion to a separate, numbered budget line (bucket four) that funds infrastructure, skills and institutes.

    Wonkhe’s analysis of the settlement described this fourth line plainly: it is “what is basically a fourth bucket.” For grant holders, infrastructure and doctoral/talent funding — underpinning every council’s ability to deliver — now sit in a separately governed pot rather than inside familiar discipline-specific budgets.

    What the restructuring means for grant holders

    For applicants and research-office staff, the bucket model changes both what gets funded and how decisions get made:

    • Fewer council-specific figures. UKRI states “a breakdown by research council is only possible for curiosity-driven research” — buckets two and three report only by Industrial Strategy sector, not by funding council.
    • Leverage expectations. UKRI targets “an average leverage ratio of at least £3 of private investment for every £1 of public investment” across strategic and innovative-company calls — expect this built into co-funding criteria.
    • Cross-council, SRO-led programmes. Buckets two and three are delivered through cross-UKRI programmes, each led by one executive-chair Senior Responsible Owner, so calls increasingly span disciplines under one programme brand.

    Curiosity-driven applicant-led research — most familiar to individual investigators — keeps its existing per-council structure and, per UKRI, sees “increases over the period” for every council. Grant holders in Industrial Strategy-adjacent fields (AI, quantum, life sciences, clean energy) should expect more programmatic, mission-shaped calls; those in curiosity-driven disciplines should expect process continuity, a larger overall pot, and some coherence-driven reallocation, such as the planned phase-out of non-recurrent Research England funds from 2027–28.

    Is UKRI cutting STFC and other councils, or just hiding the numbers?

    Search interest in “STFC cuts” reflects genuine sector anxiety, but the honest answer is that the bucket model makes council-level comparisons largely unverifiable from UKRI’s public explainer alone. The only research-council figure UKRI publishes is for applicant-led research within bucket one: the Science and Technology Facilities Council (STFC) gets £344 million of the £3.3 billion four-year applicant-led total, against £1,170 million for the Engineering and Physical Sciences Research Council and £453 million for the Medical Research Council.

    Everything STFC receives through buckets two, three or four — including large-scale infrastructure and international subscriptions, historically a significant share of its budget — is folded into cross-cutting or Industrial Strategy totals with no council attribution. This has drawn direct parliamentary scrutiny: in March 2026, UKRI chief executive Professor Sir Ian Chapman wrote to the Commons Science, Innovation and Technology Committee, giving the first detailed comparison of past and future spending under the new model and describing the shift as “not a simple reclassification” but a “fundamental change in how money flows through the organisation.” Committee chair Dame Chi Onwurah said such comparisons are “especially important for understanding what’s changing and for holding UKRI to account — particularly amid reports of research funding cuts.”

    In short: no UKRI document currently states that STFC’s overall funding is being cut, but no UKRI document currently lets anyone outside UKRI verify the opposite either — which is precisely the accountability gap the parliamentary committee is now pressing UKRI to close.

    Common questions about UKRI’s funding buckets

    How many funding buckets does UKRI actually have?

    UKRI names three priority buckets — curiosity-driven research, strategic government and societal priorities, and supporting innovative companies — plus a fourth budget line, enabling and strengthening UK R&D (£8.4 billion), which sector commentators treat as a de facto fourth bucket.

    Which UKRI funding bucket is the largest?

    Curiosity-driven research is the largest bucket at £14.5 billion over the 2026–2030 spending review period, covering applicant-led grants, Quality-related (QR) university funding, and research institutes and infrastructure supporting fundamental discovery.

    What is UKRI’s leverage ratio target for strategic funding?

    UKRI is targeting an average of £3 of private investment for every £1 of public investment across its strategic government and innovative-company buckets, with higher ratios expected specifically for programmes supporting innovative companies.

    Does the new model change how applicant-led grants are assessed?

    No — applicant-led research keeps its existing research-council structure, with every council seeing budget increases over the period; the bucket changes mainly affect strategic and industrial-strategy-linked programmes, not investigator-led applications.

    Outlook: the road to a near-£10bn annual budget

    UKRI’s annual budget rises steadily across the spending review period — from £9.22 billion in 2026–27 to £9.99 billion in 2029–30 — placing it on a trajectory toward, though not quite reaching, £10 billion a year by decade’s end. UKRI has said it will publish a single delivery plan for 2026–27 in spring 2026, and will continue “increasing the coherence of its portfolio within and across buckets” as the model beds in.

    For grant holders, the practical task now is to map pipeline applications onto the new bucket structure, track which Industrial Strategy programmes intersect with their discipline, and watch the parliamentary committee’s scrutiny sessions for council-level detail UKRI’s own explainer does not yet provide. Institutions with dedicated research administration teams are best placed to translate these bucket-level signals into concrete guidance for principal investigators preparing 2026–27 and 2027–28 calls.

  • Research Professional News Closure: Next Steps

    Research Professional News closure is confirmed: Clarivate will discontinue the publication on 31 December 2026, citing the long-term sustainability challenges of running a specialist journalism business. For UK research offices, that removes a three-decade primary-source channel for research policy and funding news, and the gap needs a deliberate replacement plan built from professional-body, funder-direct and independent-commentary sources — not a single like-for-like substitute.

    Research Professional News is the Clarivate-owned trade publication — successor to Research Fortnight and Research Europe — that has covered UK and European research policy, funding calls and higher-education strategy since the 1990s.

    What Is Happening to Research Professional News?

    Clarivate confirmed in a statement published on its Academia & Government portfolio pages that Research Professional News will discontinue publication on 31 December 2026. The company says it is exploring options with third parties to host the archive, but has committed that past content “will remain available and freely accessible to readers and the wider research community” regardless of whether such an agreement is reached.

    Emmanuel Thiveaud, quoted in Research Information’s coverage of the announcement, described three decades of “authoritative, high-quality reporting and analysis across the complex landscape of research policy, funding and higher education” and thanked the editorial team by name in the closure notice. The final edition publishes on 31 December 2026; UK, European and Funding Insight coverage continues on a business-as-usual basis until then.

    Why Is Clarivate Closing Its Research Journalism Arm?

    Clarivate frames the decision as strategic reallocation, not financial distress in its wider business. The stated rationale is a shift to focus the Academia & Government portfolio on “scalable data, insights, analytics, workflow solutions and expert services” rather than editorial journalism.

    This is a narrower move than it first appears. Clarivate’s funding-opportunities database, Pivot-RP, and its Web of Science analytics products are not part of the closure — only the specialist-journalism arm is affected. Research offices should not read this as Clarivate exiting research intelligence; it is exiting one product line within it, a distinction most coverage of the announcement has not spelled out.

    • Final publication date: 31 December 2026
    • Archive: committed to remaining free and publicly accessible
    • Unaffected: Pivot-RP funding database and Web of Science analytics
    • Affected: original editorial reporting, Funding Insight, and UK/Europe policy news

    Which Sources Fill the Research-Intelligence Gap?

    No single outlet replicates Research Professional News’s combination of daily policy reporting, funder-call tracking and sector commentary. Research offices need a three-tier stack: a professional body for practitioner context, funders’ own direct channels for primary-source accuracy, and independent commentary for cross-sector analysis.

    Source Type Coverage Best used for
    ARMA (Association of Research Managers and Administrators) Professional body UK Practitioner news round-ups, CPD, regional network updates
    UKRI direct channels (council e-alerts, Funding Finder) Funder-direct UK Primary-source funding calls and mandate changes
    Wonkhe Independent commentary UK Daily higher-education policy analysis and politics
    EARMA (European Association of Research Managers and Administrators) Professional body Europe Horizon Europe and pan-European funding context
    INORMS Global network International Cross-jurisdiction benchmarking of research-management practice

    ARMA’s UK membership network already circulates sector news and event round-ups to research managers, making it the closest practitioner-facing analogue to Research Professional News’s community role. UKRI’s own site and council-level e-alerts remain the authoritative first-party source for funding-call detail, since a trade publication was always a secondary layer over that primary data. For the wider policy debate — REF, research culture, institutional strategy — Wonkhe‘s daily briefing already covers much of the ground Research Professional News’s opinion and analysis sections held.

    How Should Research Offices Build a Replacement Workflow?

    Treat this as a migration project with a fixed deadline, not a passive wait for 31 December 2026. Research offices that rely on Research Professional News alerts for grants, mandates or REF-adjacent policy should act on three horizons.

    • Immediate: archive or bookmark any internally cited Research Professional News articles now, since URL structures may change if a third party takes over hosting.
    • Short term: subscribe research-office staff to ARMA’s news channels and set up UKRI council-specific e-alerts and Funding Finder saved searches to replace daily funding-call tracking.
    • Medium term: add Wonkhe’s daily briefing (and, for European-facing offices, EARMA’s newsletter) to cover the analytical and cross-sector commentary that funder-direct channels do not provide.

    Institutions should also audit which internal reports, board papers or policy briefings cite Research Professional News as a source, and flag those for a citation review once the archive’s final hosting arrangement is confirmed.

    Common Questions on the Research Professional News Closure

    Why is Research Professional News closing?

    Clarivate states the closure reflects a strategic refocus of its Academia & Government portfolio onto scalable data, analytics and workflow products, combined with the “long-term sustainability challenges” of running a specialist journalism business inside a data-and-analytics company.

    When does Research Professional News stop publishing?

    The final edition publishes on 31 December 2026. Clarivate has committed that the existing archive will remain freely and publicly accessible after that date, whether or not a third party takes over hosting of the content.

    What should UK research administrators use instead?

    Build a three-source stack: ARMA for practitioner news and community context, UKRI’s direct e-alerts and Funding Finder for primary funding-call data, and Wonkhe for independent cross-sector policy commentary and analysis.

    Is Clarivate exiting research intelligence altogether?

    No. Only the editorial journalism arm is closing. Clarivate’s Pivot-RP funding-opportunities database and its Web of Science analytics products continue unaffected, since the decision targets specialist journalism specifically, not the wider research-intelligence business.

    Outlook for UK Research-Policy Intelligence

    The closure removes a single point of aggregation the UK sector had relied on for nearly three decades, and no successor has consolidated its full scope by the 31 December 2026 deadline. Research offices that build a professional-body-plus-funder-direct-plus-commentary stack now will be better placed than those waiting for a single replacement to emerge, because none is likely to appear.

    For institutions building broader research-administration capability alongside this transition, CASRAI’s research administration resources cover related standards and workflow context.

  • ArXiv ORCID Authentication for Preprints

    ArXiv ORCID authentication lets a researcher link a persistent ORCID iD to their arXiv account, and it is one of two models preprint servers use to establish who an author is before a paper ever reaches peer review — the other being direct “log in with ORCID,” used by bioRxiv. Neither model performs formal identity verification in the legal sense; both rely on ORCID’s OAuth authentication to confirm that the person submitting genuinely controls the ORCID iD they claim.

    ORCID authentication is the OAuth-based process by which a researcher proves control of their ORCID iD to a third-party system — such as a preprint server — by signing in directly at orcid.org, without ever sharing a password with that third party. This distinction matters for research administrators and developers assessing how much identity assurance a preprint record actually carries.

    How does ORCID authentication work before publication?

    ORCID authentication runs on a three-legged OAuth flow, documented by ORCID’s own integration guide. A system such as a preprint server creates a “Connect your ORCID iD” link; when a researcher clicks it, they are redirected to orcid.org, sign in with their own ORCID credentials, and explicitly grant the requesting system permission to read (and, for member integrations, write) specific parts of their record.

    ORCID then returns an authorisation code, which the preprint server exchanges for an access token. That token — not a copied-and-pasted ID number — is what proves the connection is genuine. According to ORCID’s documentation, the organisation does not permit manual entry of ORCID iDs in any workflow where authenticated collection is technically possible, precisely because typed-in IDs cannot prove ownership.

    • Public API: free, available to non-commercial and commercial integrations, sufficient for basic authenticated sign-in and read access.
    • Member API: requires ORCID membership, needed to write data (such as adding the preprint itself) directly to a researcher’s record.
    • Sandbox environment: a full ORCID Sandbox testing server lets integrators build and demo the OAuth flow before ORCID’s engagement team approves production Member API credentials.

    How arXiv verifies author identity with ORCID

    arXiv treats ORCID primarily as a disambiguation and record-linking layer rather than a submission gate. Authors link an existing ORCID iD — or create one during the process — via arXiv’s account dashboard, and the platform then prefers the ORCID iD over its own internal arXiv author identifiers wherever possible “in order to facilitate better data exchange,” per arXiv’s own documentation.

    Identity assurance on arXiv sits mainly in a separate, adjacent mechanism: endorsement. As of 21 January 2026, arXiv no longer accepts an institutional email address alone as sufficient qualification for a new submitter. Under the updated policy, a new author must now satisfy one of two paths:

    1. An institutional academic/research email address and prior authorship on a paper already accepted into the relevant arXiv endorsement domain, or
    2. Direct personal endorsement from an established arXiv author already active in that same domain.

    arXiv’s own guidance notes that authors contacting a potential endorser may include a link to their ORCID profile as supporting evidence, though ORCID linkage itself is not a mandatory endorsement criterion. Misrepresenting identity or institutional affiliation is, separately, a violation of arXiv’s code of conduct and grounds for account suspension.

    How bioRxiv verifies author identity with ORCID

    bioRxiv, operated by the non-profit openRxiv, takes a more direct authentication route. The platform offers a “Log in with ORCiD” option at the account level: when a submitter authenticates this way, bioRxiv receives an ORCID-verified identifier straight from ORCID’s OAuth flow, rather than a self-typed value.

    During manuscript submission, corresponding authors can also attach ORCID iDs for themselves and co-authors, which are then carried into the preprint’s metadata. This matters for provenance: under ORCID’s documented preprint workflow, an ORCID-member preprint server can add the work to an author’s ORCID record with a “Self” relationship, and later — once a peer-reviewed version exists — a publisher can add the journal article with a “Version of” relationship linking the two, grouping the preprint and its published descendant on one authoritative record.

    arXiv vs bioRxiv: ORCID identity assurance compared

    The two platforms diverge on where, and how strongly, ORCID authentication sits in the submission path:

    Feature arXiv bioRxiv
    ORCID collection point Account linking, post-registration Optional login and/or manuscript submission
    Authentication method Account-page OAuth link to ORCID Direct “Log in with ORCiD” OAuth sign-in
    Mandatory for submission? No — recommended, not required No — optional for authors and co-authors
    Separate identity gate Endorsement policy (updated 21 Jan 2026) Basic screening for offensive/non-scientific content
    Co-author ORCID capture Not built into the submission form Can be added at submission by corresponding author

    What this means for identity assurance ahead of peer review

    ORCID authentication and identity verification are not the same thing, and conflating them overstates what a preprint record actually proves. An authenticated ORCID iD confirms that a specific, persistent researcher account is behind a submission. It does not confirm a person’s legal name, employer, or credentials — those rest on the separate affiliation and endorsement checks each platform runs independently.

    Funders are pushing this authentication layer further upstream. UK Research and Innovation (UKRI) is building mandatory ORCID iD linking into its Funding Service for project leads, co-leads and fellows, with the requirement expected to take effect roughly six months after the relevant functionality launches, targeted for 2027. That shifts identity assurance earlier — to the funding-application stage — rather than leaving it solely to the preprint or journal submission step.

    For institutions and developers building on this infrastructure, the practical takeaway is definitive: treat an authenticated ORCID iD as strong evidence of account control, and treat endorsement, institutional email, and funder-linked ORCID mandates as the separate, complementary layers that build fuller identity assurance around it.

    Frequently asked questions

    Do arXiv papers appear on ORCID?

    Yes. Once an author links their ORCID iD to their arXiv account, arXiv’s works are unambiguously connected to that researcher’s broader scholarly record, helping distinguish them from authors with similar names across other platforms and repositories.

    How do I add an arXiv preprint to ORCID?

    Authors can search by arXiv identifier directly within their ORCID record’s “Add works” tool, or link their arXiv account to ORCID so eligible works sync automatically. Manual entry of someone else’s ORCID iD is not permitted under ORCID’s collection policy.

    Does an arXiv preprint count as a publication?

    Not in the traditional peer-reviewed sense. ArXiv preprints are not peer-reviewed before posting, so most journals and funders treat them as a distinct output type — citable, but separate from the peer-reviewed version of record that may follow.

    What is the arXiv identifier?

    The arXiv identifier (or arXiv ID) is a unique code assigned to every submitted paper, used to cite and retrieve it. It is distinct from an author’s ORCID iD, which identifies the person rather than the paper.

    Looking ahead

    arXiv and bioRxiv show two workable but distinct approaches to the same problem: using ORCID’s authenticated, OAuth-based identifiers to anchor preprint authorship without claiming to verify legal identity outright. As funders such as UKRI extend ORCID requirements into the funding-application stage, the identity-assurance chain around research outputs is likely to start earlier and grow more consistent — well before a manuscript ever reaches a preprint server or a peer-review desk.

    For research administrators mapping authorship and contribution practices onto institutional systems, understanding exactly what an authenticated ORCID iD does and does not prove is a prerequisite for sound research administration policy — not an afterthought.

  • Researcher Unique Identifiers: How ORCID Links ISNI and VIAF

    A researcher unique identifier such as an ORCID iD resolves name ambiguity by acting as a bridge between the researcher-controlled scholarly record and the library world’s authority-control infrastructure — principally ISNI and VIAF — so that a catalogue entry, a national bibliography record, and a journal byline all point to the same verified person, even when names are shared, transliterated, or changed over time. This matters because author-name collision is a routine, measurable problem in large catalogues and citation databases.

    ORCID (Open Researcher and Contributor ID) is a free, persistent, 16-digit identifier that a researcher registers and controls directly, distinguishing them from every other person with a similar or identical name. ORCID is self-asserted, while ISNI and VIAF are authority-controlled — built by libraries, not by the individuals they describe. Understanding how these three systems interlock explains how name disambiguation actually works in catalogues, not just in publisher submission forms.

    What is a researcher unique identifier, and why does ambiguity matter?

    A researcher unique identifier is a persistent code — separate from a person’s name — that stays fixed even when a name changes, is spelled inconsistently, or is shared by many people. Catalogues holding millions of records inevitably contain multiple contributors named, for example, “J. Kim” or “M. Garcia,” and without a persistent identifier, a cataloguer or search algorithm has no reliable way to tell them apart.

    National bibliographies, institutional repositories, and citation indexes all depend on authority control — the library-science practice of establishing one authoritative name form and linking variants to it — and name collision undermines that practice. A researcher unique identifier gives authority control a machine-actionable anchor that survives name changes, script variation, and homonymy.

    How does ORCID differ from ISNI and VIAF?

    ORCID, ISNI, and VIAF solve overlapping problems under different governance models: ORCID is researcher-asserted, ISNI is registry-assigned and spans all creative and public identities, and VIAF aggregates national library authority files. None replaces the others — each addresses a different point in the identity-verification chain.

    ISNI (International Standard Name Identifier) is an ISO-certified global standard number — ISO 27729 — issued to the public identities of contributors across research, publishing, music, film, and the visual arts. Unlike ORCID, an ISNI is typically assigned by a registration agency drawing on authoritative sources such as library catalogues and rights-management data, not registered by the individual. VIAF (Virtual International Authority File), hosted by OCLC, combines name-authority files from dozens of national libraries into a single clustered record, so German, Japanese, and English catalogue name-forms for one researcher resolve to a single entry.

    System Governing standard / host Who assigns it Primary scope
    ORCID ORCID, Inc. (non-profit) The researcher, by self-registration Active researchers and contributors to scholarly output
    ISNI ISO 27729 Registration agencies, from authoritative source data Public identities across research, publishing, music, film, and visual arts
    VIAF OCLC (aggregation service) Automated clustering of national library authority files Name-authority records held by national and research libraries worldwide

    The Book Industry Study Group summarised the practical distinction in its October 2025 analysis: “ORCID specializes in the active research community, whereas ISNI provides broader coverage of public names across cultural sectors.” That division of labour is precisely why the two systems were designed to interoperate rather than compete.

    How do ORCID and ISNI interoperate?

    ORCID and ISNI interoperate through a formal, documented partnership, not an informal data-sharing arrangement. The two organisations issued a joint statement on interoperation on 22 April 2013, committing to link records and exchange public data so a researcher’s ORCID iD and ISNI can be cross-referenced automatically rather than matched by hand.

    A specific technical mechanism underpins this: ORCID was allocated an exclusive block of numbers within the ISNI numbering range, so ORCID-issued identifiers cannot collide with identifiers issued directly by ISNI registration agencies. Researchers can link an existing ISNI to their ORCID record, which then propagates into library authority files that consume ISNI data — including, per the Library of Congress’s 2013 discussion paper for the Program for Cooperative Cataloging, catalogues maintained through the NACO name-authority cooperative. The British Library was a founding partner in the ISNI project itself, which is why UK legal-deposit and national-bibliography workflows engaged with ISNI/ORCID linkage early.

    How does VIAF feed ISNI and national library catalogues?

    VIAF functions as the foundational aggregation layer that both ISNI and individual library catalogues draw on. Its clustering algorithms — built to match and merge name-authority records describing the same person across dozens of national libraries — were adapted to underpin ISNI’s own matching system when ISNI was established, per the scholarly literature on the two initiatives, including the 2014 IFLA analysis of ISNI and VIAF as tools for “trustfully consolidating identities.”

    In practical cataloguing terms, the chain typically runs as follows:

    • A national library creates or updates an authority record, drawing on VIAF to see how the name is represented across other libraries’ catalogues.
    • If an ISNI exists, or is newly assigned, it is added as a globally unique, persistent cross-reference.
    • If the researcher’s ORCID iD is linked to that ISNI, the library record connects to their self-maintained, current publication and affiliation history.
    • A catalogue user searching by name inherits the benefit automatically: variant name-forms and same-name collisions resolve to one confirmed identity.

    Crossref reinforces the same chain from the publishing side: its metadata schema captures ORCID iDs at deposit and auto-updates newly published works into a researcher’s ORCID record, keeping the researcher-asserted layer synchronised with the bibliographic layer that libraries later harvest into VIAF and ISNI-linked authority data.

    Answer-first Q&A: common questions about researcher identifiers

    Is ResearcherID the same as ORCID?

    No. ResearcherID is a Web of Science-specific identifier generated automatically when a researcher creates a Web of Science profile, tied to that publisher’s indexed content. ORCID is publisher-neutral, self-managed by the researcher, and can be attached to outputs from any publisher, including datasets, patents, and grants — not just Web of Science-indexed articles.

    What is a research identifier?

    A research identifier is a persistent, structured code assigned to a researcher, contributor, or their output to distinguish it unambiguously from similarly named people or works. Unlike a name, it does not change with marriage, transliteration, or spelling variation, which makes it the stable anchor that catalogues, funders, and publishers rely on for accurate attribution.

    Who provides an ORCID iD?

    ORCID, Inc., a non-profit organisation, issues ORCID iDs free of charge directly to individual researchers who self-register. Institutions, publishers, and funders do not assign ORCID iDs on a researcher’s behalf; they can only require or encourage registration and integrate the resulting identifier into their own systems, such as manuscript-submission or grant-application platforms.

    Are ORCID and Scopus ID the same?

    No. The Scopus Author Identifier is generated automatically by Elsevier’s Scopus database for any author with an indexed publication, whereas an ORCID iD is registered directly by the researcher and works across all publishers, not just those indexed in Scopus. Researchers can link the two, but each is maintained by a different organisation under a different assignment model.

    What does this mean for institutions and bibliographies?

    For research administrators and repository managers, the ORCID-ISNI-VIAF chain means catalogue-level disambiguation is no longer solely manual. Embedding an ORCID iD at deposit — in a repository record, thesis submission, or grant report — creates a traceable path into national authority files without extra cataloguer effort, provided the receiving system consumes ISNI or VIAF data.

    For national libraries, workloads increasingly consist of linking existing identifiers rather than establishing new name forms — less labour-intensive, though cataloguer judgement is still required where automated matching is ambiguous, such as with common transliterated names.

    The direction set out in the 2013 ORCID-ISNI joint statement — a shared scheme where one number represents an individual across both systems — remains the long-term goal, not the current default. Institutions building repository or CRIS infrastructure should treat ORCID capture as the entry point, ISNI/VIAF linkage as the library-side consequence, and Crossref metadata as the mechanism keeping the two synchronised as new outputs are published.

    CASRAI’s Dictionary of research administration terms maintains definitions for persistent identifiers and related concepts, and readers working on attribution practices more broadly may also find the CASRAI authorship resource pillar relevant background.

  • bioRxiv Review Process: Screening Explained

    bioRxiv review is not peer review — it is a two-stage screening process. In-house staff and volunteer Principal Investigators check every submission for plagiarism, non-scientific content, inappropriate article types, and material that could endanger public health, typically within 24-48 hours. Roughly 5% of submissions do not meet bioRxiv’s posting criteria and are returned, escalated for discussion, or declined outright.

    bioRxiv is a preprint server for the life sciences, operated by the non-profit openRxiv, that posts complete but unpublished manuscripts online before formal journal peer review begins. Understanding what its screening actually checks for — and what happens when a submission does not clear it — helps authors avoid the delays that come from an incomplete or out-of-scope submission.

    What does bioRxiv’s review actually screen for?

    bioRxiv’s screening exists to keep the server usable and safe, not to certify scientific validity. Every submission is checked against a fixed set of criteria before it is allowed to post.

    According to bioRxiv’s own FAQ, all articles are screened on submission for four things: plagiarism, non-scientific content, inappropriate article types, and material that could endanger the health of individual patients or the public. That last category explicitly includes studies describing dual-use research of concern, and work that challenges or could compromise accepted public health advice on infectious disease transmission, immunisation, or therapy.

    • Automated text analysis for plagiarism and content already published elsewhere
    • Manual checks that the manuscript is a genuine research article, not a review, opinion piece, protocol-only submission, or product announcement
    • Screening for images or details that could identify a patient or study participant
    • Assessment of whether findings could alarm or mislead the public if posted without peer review

    Manuscripts already published in a journal cannot be submitted, and a preprint cannot sit on both bioRxiv and its sister server medRxiv simultaneously — doing so results in withdrawal of the article.

    How does the two-stage screening process work?

    bioRxiv runs a defined two-step pipeline rather than a single editorial check. Both stages must be passed before a manuscript posts.

    The first stage is in-house screening. According to bioRxiv’s screening-procedures notice, staff with scientific and editorial backgrounds verify that submission fields are complete, that group authors are not mis-listed as individuals, and that the manuscript is an appropriate article type — a research article is accepted; a narrative review, commentary, opinion piece, or standalone protocol is not. This stage also runs the automated plagiarism check.

    The second stage is Affiliate screening. Volunteer Principal Investigators, known as bioRxiv Affiliates, ask two questions: does the manuscript present biological research, and is there potential for public harm from posting it as a preprint? If an Affiliate has concerns on either point, the submission is flagged for further in-house discussion rather than posted automatically.

    bioRxiv states that this combined process “typically takes 24–48 hours, but can take longer over weekends and holidays, or if the submission requires in-house discussion and further correspondence with authors.” Its FAQ separately notes preprints “usually appear on bioRxiv within 72 hours” once screening and formatting are complete — the wider window accounts for queueing and the PDF-to-HTML conversion that follows posting.

    What happens when a preprint is held, escalated, or declined?

    Screening produces one of five outcomes, not a simple accept/reject binary. Manuscripts can be escalated at any stage for discussion by bioRxiv’s Content Team and, where needed, its Founders or external advisors — commonly because the article type or content falls outside scope, or because it contains conclusions that could cause public alarm, such as data disputing an established toxicity or carcinogenicity finding.

    Outcome What it means Typical trigger Author’s next step
    Posted Preprint goes live, usually within 24-72 hours Passes in-house and Affiliate checks No action needed; revisions remain possible later
    Returned for correction Sent back before posting Missing metadata, formatting errors, incomplete author or funder details Correct fields in the Author Area and resubmit
    Escalated for discussion Flagged for internal review Scope question, or risk of misleading/alarming the public Await correspondence; respond promptly to queries
    Transferred to medRxiv bioRxiv submission closed; author redirected by email Manuscript judged better suited to medRxiv’s clinical/health scope Resubmit via submit.medrxiv.org, which runs a separate screening team
    Declined Does not proceed to posting Fails scope or safety criteria, or judged “better disseminated after peer review” due to public-impact risk Address the specific concern and pursue journal peer review, or resubmit once the issue is resolved

    bioRxiv reports that approximately 5% of submissions are found not to meet its posting criteria. Content judged out of scope for public-health reasons is typically redirected to medRxiv rather than declined outright, since the two servers are co-managed but apply separate screening policies.

    What should authors do if their submission is held or declined?

    The correct response depends on which of the outcomes above applies. Treating every hold as a rejection — or every rejection as final — wastes time that a targeted fix would save.

    • If returned for correction: fix the flagged metadata field (author list, affiliations, funder ROR ID, special characters) directly in the Author Area; this is usually resolved within a day.
    • If escalated: respond promptly and specifically to any correspondence from bioRxiv’s Content Team — vague or delayed replies extend the discussion period.
    • If redirected to medRxiv: follow the email instructions to resubmit at submit.medrxiv.org; the bioRxiv submission is closed and cannot be revived.
    • If declined for scope or article type: check the FAQ’s excluded-content list before resubmitting — narrative reviews, case reports, hypothesis papers without new data, and standalone protocols are structurally out of scope, not fixable by rewording.
    • If declined for public-harm risk: bioRxiv’s stated position is that such findings are “better disseminated after peer review” — pursue a journal submission rather than repeated resubmission to the preprint server.

    Authors remain solely responsible for submitted content, including material produced with generative AI tools; AI systems are not permitted to be listed as authors. Institutional research-integrity offices should treat this authorial-responsibility principle consistently with their own authorship criteria and contributor-responsibility standards, since a preprint host’s screening does not substitute for an institution’s own compliance checks.

    Frequently asked questions

    Is bioRxiv reputable?

    Yes. bioRxiv is widely used across the life sciences and is indexed by Google Scholar, Crossref, Europe PubMed Central, and PubMed for NIH-funded work. It is not peer-reviewed, but its screening process and non-profit governance under openRxiv are well documented and independently verifiable.

    Why do people use bioRxiv?

    Authors use bioRxiv because formal peer review can take months, and preprints let other scientists see, discuss, and comment on findings immediately. It also lets researchers establish priority via a timestamped, citable DOI before journal publication concludes.

    Who owns bioRxiv?

    bioRxiv is operated by openRxiv, a non-profit founded by Cold Spring Harbor Laboratory. It is funded by a consortium including the Chan Zuckerberg Initiative, the Sergey Brin Family Foundation, Caltech, Imperial College London, MIT, and Stanford — no single commercial owner controls the server.

    Is bioRxiv peer-reviewed?

    No. bioRxiv preprints are not certified by peer review, edited, or typeset before posting. Some manuscripts undergo peer review elsewhere concurrently, and those reviews may appear alongside the preprint on bioRxiv’s dashboard, but posting itself only requires passing screening.

    What this means for institutions and authors

    bioRxiv’s screening model draws a clear line that research-administration offices should reinforce internally: screening filters for scope, safety, and originality, while peer review evaluates scientific validity. The ICMJE’s Recommendations similarly caution that preprints have not been peer reviewed and should be identified as such wherever they are cited or discussed publicly. COPE’s guidance on preprints makes the same distinction, placing responsibility for research-integrity safeguards at this stage jointly on the server’s screening and the submitting institution.

    For authors, the practical takeaway is straightforward: a held or declined submission is almost always a scope, formatting, or safety issue with a defined remedy, not a verdict on the science. Reading bioRxiv’s excluded-content list and funder/author metadata requirements before submission remains the single most effective way to clear bioRxiv review on the first pass.

  • CRediT Taxonomy Generator Tools: A Vetting Guide

    A credit taxonomy generator turns a list of co-authors and ticked NISO CRediT roles into ready-to-paste manuscript text. The strongest tools quote NISO’s role definitions verbatim and start with nothing pre-selected; the weaker ones blur role boundaries, default every author into every box, or ignore the degree-of-contribution extension some publishers require — misrepresenting the exact scope a research office is expected to vouch for at submission.

    CRediT (Contributor Roles Taxonomy) is a standardised list of 14 roles, formalised as ANSI/NISO Z39.104-2022, used to describe the specific contribution each author made to a published research output. CASRAI originated the CRediT contributor role taxonomy in 2014. The standard is now stewarded by NISO as ANSI/NISO Z39.104-2022, and the canonical role definitions live on credit.niso.org, not on any third-party generator site.

    What Is a CRediT Taxonomy Generator?

    A CRediT taxonomy generator is a web form or spreadsheet template that lets contributors tick which of the 14 NISO-defined roles they held on a manuscript, then formats the selections into text a journal’s submission system will accept. It does not decide who counts as an author. It records role assignments against an already-agreed author list.

    Several such tools now rank for this query, including standalone generators, an open-source script, and embedded tools on publisher and university sites. All draw from the same 14-role taxonomy; the difference between a trustworthy tool and a misleading one is how faithfully each implements the definitions and defaults.

    Where CRediT Generator Tools Get It Right

    The best generator tools do three things well. They reproduce NISO’s role descriptors without paraphrasing, so the output text matches what a reviewer expects to see. They format consistently for the receiving journal — per-author or per-role layout, since most publishers accept either but house style varies. And they speed up a genuinely tedious task: coordinating role assignment across five, ten, or twenty co-authors by email is slow, and a shared form reduces the back-and-forth.

    • Verbatim NISO definitions reduce drift from the canonical wording.
    • Structured input forces the co-author conversation to happen before submission, not after a reviewer asks for it.
    • Machine-readable output can flow into ORCID records and CRediT-aware repository metadata.

    Where Auto-Generated Wording Misrepresents Role Scope

    The taxonomy itself is precise; generator tools do not always preserve that precision in their defaults, their UI copy, or their handling of edge cases. Four patterns recur across the tools currently ranking for CRediT-generator queries.

    Confusion pattern What NISO actually defines Where generators typically go wrong
    Methodology vs Investigation Methodology is designing the approach; Investigation is executing it — collecting data or running experiments Checkbox interfaces let one author tick both by default, collapsing a design/execution distinction reviewers rely on
    Writing – original draft vs review & editing Original draft covers only the initial written version, “including substantive translation”; everything after that is review & editing Generators frequently pre-tick “original draft” for every listed writer, inflating a role NISO reserves for the one or two people who produced the first full text
    Resources vs Funding acquisition Resources means materials, reagents, instruments, or samples; Funding acquisition means securing the money for the project Free-text or auto-suggest tools conflate a grant-holder with a materials donor, crediting the wrong contribution type
    Degree of contribution (lead/equal/supporting) An optional extension some publishers (Wiley, Elsevier, Taylor & Francis) support; Nature, Cell, Science and PLOS generally do not Tools that hardcode the extension on or off regardless of target journal produce a statement the receiving publisher will reject or silently strip

    None of these are bugs in the strict sense. They are design choices — permissive defaults, generic UI copy, one-size-fits-all publisher handling — that push the output away from what NISO’s descriptor text actually says. An office that recommends a tool without checking these defaults is co-signing whatever scope drift the tool introduces.

    How Should a Research Office Vet a CRediT Generator Before Recommending It?

    Before adding a generator link to an author-guidance page or onboarding pack, check the following against the tool itself, not its marketing copy.

    • Definitions are quoted, not paraphrased. Compare the tool’s role descriptions word-for-word against credit.niso.org — any deviation is a red flag.
    • No role starts pre-ticked. A tool that defaults authors into roles they have not confirmed invites gift-authorship-style overclaiming.
    • Degree of contribution is journal-aware, not hardcoded. The tool should let the user turn lead/equal/supporting on or off, since Nature and Cell workflows do not use it while Wiley and Elsevier workflows often do.
    • Attribution to NISO is visible. A tool that implies it owns or authored the taxonomy — rather than implementing a NISO standard originated by CASRAI in 2014 — is misrepresenting provenance, which matters for institutional sign-off.
    • Data handling is transparent. Author names and role data entered into a third-party form should not be retained without a stated policy; check before pointing an entire department at an external site.
    • It is tested against edge cases. Preprints, corrections, and revised manuscripts each raise questions a naive generator will not surface — see the practical example below.

    The University of Dundee’s 2025 CRediT Taxonomy Register is a useful comparison case: rather than adopting an external generator wholesale, the institution built its own tracking template for research leaders, designed specifically for internal recognition and audit rather than journal formatting alone. That is one practical model for offices that want the taxonomy’s structure without inheriting a third-party tool’s defaults.

    Common Questions About CRediT Generator Tools

    What is a CRediT taxonomy generator?

    A CRediT taxonomy generator is a form or tool that lets contributors select which of the 14 NISO CRediT roles they held, then outputs formatted text for a journal’s author contribution statement. It does not decide authorship — it only records roles against an already-agreed author list, and its reliability depends on how faithfully it reproduces NISO’s definitions.

    Are CRediT statement generators accurate?

    Accuracy varies by tool. Generators that quote NISO’s role definitions verbatim and leave every role unticked by default tend to be reliable. Tools that pre-populate roles, merge overlapping definitions such as Methodology and Investigation, or ignore the lead/equal/supporting extension can misstate what a contributor actually did.

    Does a CRediT statement decide who counts as an author?

    No. CRediT records the type of contribution made to a published output; it does not set authorship eligibility. Authorship is governed separately by a journal’s own policy, most commonly the ICMJE criteria, and CRediT is applied only after the author list itself has been agreed.

    Can a CRediT generator resolve an authorship dispute?

    Not on its own. A generator can make each contributor’s claimed roles visible and comparable, which helps surface disagreements early. Resolving a dispute still requires a documented conversation among co-authors and, where necessary, escalation to the institution’s research integrity office.

    Implications for Research Offices and Editors

    Research offices that link to a CRediT generator from an authorship policy page implicitly endorse its defaults. If that tool pre-ticks roles or applies degree-of-contribution formatting a target journal does not accept, the office inherits the correction burden when an editor bounces the submission back. The fix is not to avoid generators — coordinating role assignment across a large author list without one is genuinely harder — but to treat the tool like any other compliance software: checked against the standard it implements, not assumed correct because it is popular.

    This also matters for how contribution data eventually reaches persistent research metadata. A CRediT statement generated with inflated or merged roles does not stay confined to a PDF; where publishers push CRediT into ORCID records or repository metadata, sloppy generator output propagates into machine-readable contribution history that outlives the paper itself.

    What This Means Going Forward

    CRediT generator tools solve a real coordination problem, and the better ones — those that quote NISO verbatim and default to nothing selected — are a legitimate time-saver for multi-author teams. The risk sits with tools that treat the 14 roles as a generic checklist rather than a precisely defined set of contributor roles, each with boundaries that matter to editors, funders, and future readers of the record. A research office vetting a generator should apply the same standard it applies to any compliance tool: verify it against the source, not its marketing page.

  • UK Research Council PhD Funding Governance Guide

    UK Research Council PhD funding flows from UK Research and Innovation (UKRI) to universities as block grants, not to students directly — institutions then allocate stipends, fees and training support through Doctoral Training Partnerships (DTPs) or Centres for Doctoral Training (CDTs), each carrying distinct governance, co-investment and reporting duties that a graduate school must manage for the full multi-year life of the award.

    UK Research Council PhD funding is the collective term for doctoral studentship grants awarded by UKRI’s seven discipline-specific Research Councils — AHRC, BBSRC, ESRC, EPSRC, MRC, NERC and STFC — to UK higher education providers, which then administer stipends, fees and training support on the Council’s behalf.

    What is UK Research Council PhD funding, and who administers it?

    UKRI does not fund doctoral researchers directly. It issues training grants to higher education providers (HEPs) or consortia of universities and non-academic partners, and those institutions recruit, admit and pay students against the terms of the grant. For 2026/27, UKRI’s minimum stipend is £21,805 a year outside London and £23,805 within it, alongside at least £5,238 towards tuition fees — figures confirmed by sector reporting in April 2026.

    Most studentships also carry a Research Training Support Grant (RTSG), commonly around £5,000 a year, to cover fieldwork, consumables or conference costs. Graduate schools administer stipend, fees and RTSG as a single package per student, but the governance model wrapped around that package differs sharply between a DTP and a CDT.

    How do DTPs and CDTs differ in governance?

    A Doctoral Training Partnership is typically a consortium of universities pooling a Research Council’s training grant to fund a broad, multidisciplinary spread of studentships. A Centre for Doctoral Training is a single institution or tight partnership built around one strategic research theme, with mandatory, deeply integrated industry co-delivery. The consequence: a DTP’s management board answers primarily to partner universities, while a CDT’s governance is shared, by design, with external co-investors.

    Feature Doctoral Training Partnership (DTP) Centre for Doctoral Training (CDT)
    Structure Consortium of universities, broad disciplinary spread Single institution or focused partnership, one strategic theme
    Governance lead Management board with an administrative lead partner Co-governed with non-academic/industry partners
    Non-academic co-investment Encouraged (e.g. ESRC targets at least 15% of studentships involving non-academic collaboration) Mandatory — at least 20% of costs, rising to 40–50% in some strategic areas
    Cohort model Larger, more diverse cohort across partner institutions Smaller, thematically focused cohort, typically four years
    New-funding alignment Doctoral Landscape Awards Doctoral Focal Awards

    Some Councils layer further structures on this base model. Industrial CASE (iCASE) studentships, run by STEM Councils such as EPSRC, BBSRC, MRC and NERC, split funding and supervision between a university and a named industry partner. AHRC’s Collaborative Doctoral Partnerships extend the principle to museums, archives and trusts.

    What financial governance and co-investment rules apply?

    The single biggest governance distinction between the two models is the co-investment threshold. UKRI guidance requires CDTs to secure a minimum of 20% of programme costs from non-academic partners, rising to 40–50% for centres in strategic priority areas — a binding commitment a graduate school’s finance office must track and evidence across the life of the award, not just at bid stage.

    DTPs operate with more flexibility. UKRI provides a training grant covering a set number of “notional studentships,” and partnerships can expand beyond that minimum through co-funding — for example, NERC requires a student to be at least 50% funded by its training grant before that student counts as a NERC-funded place. This flexibility helps graduate schools running large, multi-Council portfolios, but means eligibility for any individual studentship needs award-by-award verification rather than a single fixed rule.

    • Stipend and fee payments are made against the lead institution’s account, not per-student to UKRI.
    • RTSG allocation across individual projects is at the discretion of the DTP or CDT management board.
    • Co-investment from industry partners must be evidenced in financial reporting, not merely pledged at application.
    • Studentships cannot normally combine with other public funding, such as postgraduate loans or NHS bursaries.

    What reporting and compliance duties fall on the lead institution?

    The lead university in a DTP consortium, or the host institution of a CDT, carries formal financial reporting responsibility to UKRI, including interim and final expenditure statements covering the full grant period. Graduate schools and doctoral colleges are typically the operational point of accountability for this reporting, even where the legal grant sits with the university’s central finance function.

    Compliance extends beyond finance. Award holders must embed equality, diversity and inclusion principles in recruitment, support and programme design — a requirement UKRI applies to both Landscape and Focal awards under its core doctoral training offer. Graduate schools must also track the cap limiting international studentships to a defined proportion of a university’s total UKRI-funded places, and confirm any studentship combining loan and stipend funding has been correctly unwound before disbursement.

    How does the shift to Landscape and Focal Awards affect existing CDTs and DTPs?

    UKRI has restructured new doctoral training funding around two award types: Doctoral Landscape Awards, broad flexible investments across subject areas, and Doctoral Focal Awards, targeted at strategic or emerging research themes. Per UKRI’s doctoral training investment framework page, last updated 10 April 2026, “ongoing doctoral training partnerships (DTPs) align with doctoral landscape awards,” while “ongoing centres for doctoral training (CDTs) align with doctoral focal awards.”

    This is a forward-facing reclassification, not a retroactive one: existing CDTs and DTPs continue operating under their original award terms for the duration of the current funding period. New funding rounds, however, are issued exclusively as Landscape or Focal awards, which can fund the same activity as legacy DTPs and CDTs but with greater flexibility. Graduate schools managing a live, multi-year CDT should expect no immediate change to reporting terms — but should budget for the next renewal to arrive under the new architecture.

    Frequently asked questions

    What is the difference between a CDT and a DTP?

    A Centre for Doctoral Training concentrates funding on one strategic theme with mandatory industry co-investment of at least 20% and shared governance with non-academic partners. A Doctoral Training Partnership spreads funding across a broader disciplinary range through a university consortium, governed by an academic-led management board with more flexible co-funding arrangements.

    What is a Centre for Doctoral Training?

    A Centre for Doctoral Training is a UKRI-funded, cohort-based doctoral programme, typically four years long, built around a single strategic research theme and co-developed and co-delivered with industry or other non-academic partners. New funding for this model is now issued to universities as a Doctoral Focal Award rather than as a new CDT.

    Why is the DTP label being phased out for new awards?

    UKRI has moved from scheme-based grants to a two-award framework to increase flexibility. New funding is now allocated as Doctoral Landscape Awards or Doctoral Focal Awards rather than as new DTPs or CDTs, though every existing DTP continues operating unchanged under its original grant terms.

    What is a Doctoral Training Partnership?

    A Doctoral Training Partnership is a consortium-based UKRI funding model in which several universities pool a Research Council training grant to support a broad, multidisciplinary cohort of PhD studentships, governed by a joint management board with an administrative lead institution that reports expenditure to UKRI on the consortium’s behalf.

    Implications for graduate schools and doctoral colleges

    For institutional leaders, the governance workload of a CDT or DTP does not end at the award letter. Lead institutions must evidence co-investment, reconcile RTSG discretion against project needs, and maintain audit-ready expenditure statements across award periods that commonly run four or more years — spanning multiple UKRI reporting cycles and, increasingly, a mid-lifetime transition in award architecture.

    Graduate schools should treat the Landscape/Focal transition as a compliance planning trigger: existing CDT and DTP terms remain valid, but any renewal or new studentship round should be assessed against the current framework, not assumed to follow legacy rules. This affects how doctoral colleges structure supervisory panels, partner agreements and financial sign-off within the wider research administration function, and should prompt a fresh look at admissions and EDI processes at each renewal, rather than treating them as one-off conditions.